Etoposide Plus Lobaplatin Versus Etoposide Plus Cisplatin for Patients With Limited Small-cell Lung Cancer

Clinical trial NCT03613597 · UNKNOWN

Trial details

NCT number: NCT03613597
Sponsor: Guizhou Medical University
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Small-cell Lung Cancer

Start date: 2018-06-01
Primary completion: 2021-01-01
Enrollment: 118

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.